AstraZeneca commences phase III trial of Seroquel for treatment of bipolar disorder Sep. 13, 2000 No Comments
Inhale and Lilly reinitiate development of inhalable Forteo; discontinue other program Sep. 8, 2000 No Comments
Flavopiridol, a known antitumor agent, now reported effective in models of vascular injury Sep. 7, 2000 No Comments
FDA approves ciprofloxacin for treatment of postexposure inhalational anthrax Sep. 7, 2000 No Comments
RSS